NCT01910077View on ClinicalTrials.gov

Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

November 30, 2013

Conditions
Immunosuppression
Interventions
DRUG

Tacrobell capsule 1mg

1 capsule, oral, over the period I\&II(crossover)

DRUG

Prograf capsule 1mg

1 capsule, oral, over the period I\&II(crossover)

Trial Locations (1)

Unknown

Seoul national university hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY